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Abstract
Background: Perioperative bleeding is a predictor of morbidity following liver resection. The
transfusion-related score (TRS), which is derived from five variables (cirrhosis, preoperative haemoglobin
level, tumour size, vena cava exposure and associated extraliver surgical procedure), has been proposed
to predict the likelihood of transfusion in liver resection.
Objective: The purpose of this observational study was to evaluate the external validity of the TRS.
Methods: In a retrospective, monocentre, observational cohort study of patients undergoing elective
liver resection surgery, data for transfused and non-transfused patients were compared by univariate
analysis. The TRS was calculated for each patient. The frequency of transfusion was calculated for each
score level. The accuracy of the TRS was evaluated using the area under the receiver operator charac-
teristic curve (AUC).
Results: A total of 205 patients submitted to liver resection were included. Of these, 48 (23.4%) patients
received a blood transfusion. There was no significant difference between transfused and non-transfused
patients in age, American Society of Anesthesiologists (ASA) score or cirrhosis. The AUC for the TRS was
0.68 (95% confidence interval 0.59–0.77). Among TRS items, only vena cava exposure and associated
surgical procedures were significantly associated with risk for transfusion.
Conclusions: In the present population, the TRS appeared to serve as a weak predictor of perioperative
transfusion. This study confirms that the external validity of the transfusion predictive score should be
subject to further investigation before it can be implemented in clinical use.
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Introduction
Despite improvements in surgical and anaesthetic techniques,
postoperative morbidity following liver resection remains
high.1–5 Perioperative bleeding is one of the major predictors
of morbidity4–6 and blood transfusion is required in 10–38% of
patients undergoing liver resection.7,8 Preoperative assessment of
the risk for transfusion is useful for enhancing the information
given to patients and in the development of a perioperative strategy
to minimize the risk.8–11
The transfusion-related score (TRS) was proposed by Pulitanò
et al. to predict the likelihood of transfusion in liver resection.8
The score was found to have good overall accuracy, but was devel-
oped in a retrospective and monocentre study. The present
authors hypothesized that the TRS might be used to accurately
predict units of red blood cell (RBC) transfusion at the study liver
surgery centre. The purpose of this study was to evaluate the
external validity of the TRS in a different population of patients
undergoing liver resection.
The abstract of this study was presented at the ASA Congress, 15−19 October
2011, Chicago, IL, and SFAR Congress, 21−24 September 2011, Paris.
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Materials and methods
According to French legislation for the regulation of clinical
research, requirements for the provision of informed consent
were waived because the present study was retrospective and
observational.
Patients
A retrospective, monocentre, observational cohort study in con-
secutive patients submitted to elective liver resection during 2008
and 2009 was performed. Standard anaesthesia monitoring was
applied perioperatively. A radial arterial catheter and venous
central catheter were placed for major hepatectomy.12 Anaesthesia
was induced and maintained at the discretion of the attending
anaesthesiologist. Haemoglobin blood levels were repeatedly esti-
mated using a HemoCue Hb 201+ (HemoCue France, Meaux,
France). Transfusion criteria followed the American Society of
Anesthesiologists (ASA) Task Force and Agence Française de
Sécurité Sanitaire recommendations13,14 for 7–10 g/dl according to
cardiovascular status. A haemodynamic strategy with fluid restric-
tion during hepatic resection was applied.
All elective liver surgeries were performed by any of five senior
hepatobiliary surgeons. Major liver resection was defined as
the resection of three or more hepatic segments. Liver parenchymal
transection was conducted using an ultrasonic dissector
(Dissectron®; Laboratoire Integra Neurosciences, Saint Priest,
France), the Kelliclasie technique or bipolar coagulation. Intermit-
tent pedicular clamping was performed using a protocol of 15 min
of clamping followed by 5 min of non-clamping.15 Inferior vena
cava clamping was performed when necessary. The hanging
manoeuvre was used to facilitate the anterior approach in major
liver resections.16–18
Transfusion-related score
The TRS is derived from five variables: cirrhosis; preoperative
haemoglobin level of ≤12.5 g/dl; tumour size of >4 cm; need for
inferior vena cava exposure, and associated extraliver surgical pro-
cedure. Each variable can be assigned 1 point and the sum of these
points establishes the TRS.8
Data collection
The following data were collected from medical records: demo-
graphic data, including patient age, sex, body mass index, ASA
score, malignant or benign nature of the tumour, and presence of
cirrhosis, cardiopulmonary disease and diabetes; surgical data,
including the number of resected segments, tumour size,
perioperative vena cava exposure, any associated surgical pro-
cedure (bilioenteral anastomosis, associated colorectal, pancreatic
or renal resections) and duration of surgery; preoperative haemo-
globin blood levels, and the number of units of RBC transfused
intraoperatively and until postoperative day 5.
Statistical analysis
Data for transfused and non-transfused patients were compared
by univariate analysis using Fisher’s exact test or the Mann–
Whitney test as appropriate. The plasma haemoglobin level asso-
ciated with risk for transfusion was investigated using the Mann–
Whitney test with different cut-off values. The frequency of
transfusion at each score level was calculated. The accuracy of the
TRS was evaluated using the area under the receiver operator
characteristic (ROC) curve (AUC).
Data are presented as the median [interquartile range (IQR)] or
number (percentage). All analyses were two-tailed; a P-value of
<0.05 was accepted as indicating statistical significance. Statistical
analysis was performed using stata Version 9.2 (StataCorp LP,
College Station, TX, USA).
Results
A total of 205 consecutive patients submitted to scheduled liver
surgery during the study period were included. Forty-eight
(23.4%) patients were transfused; they received a median of 2
units (IQR: 2–4 units) of RBC. Demographic and surgical data for
transfused and non-transfused patients are displayed in Table 1.
There were no significant differences between transfused and
non-transfused patients in age, ASA score or presence of cirrhosis.
The distribution of RBC units among the 48 transfused patients is
detailed in Fig. 1.
Among the items contributing to the TRS, a preoperative
haemoglobin level cut-off of 12.5 g/dl, tumour size and cirrhosis
were not significantly associated with transfusion in univariate
analysis, whereas inferior vena cava exposure and associated sur-
gical procedures were significantly associated with risk for trans-
fusion (P = 0.012 and P = 0.029, respectively). Univariate analysis
showed a preoperative haemoglobin level of <12.3 g/dl to be asso-
ciated with transfusion (P = 0.008).
Transfusion rates for each TRS level are reported in Table 2 and
Fig. 2. For the 163 patients (of the total population of 205
patients) for which the TRS was available. The ROC AUC for the
original TRS was 0.68 [95% confidence interval (CI) 0.59–0.77]
(Fig. 3).
Using a preoperative haemoglobin cut-off value of 12.3 g/dl as
one item in the score led to an AUC of 0.69 (95% CI 0.58–0.76).
Discussion
The current study was designed to evaluate the external validity of
the TRS in predicting perioperative transfusion during liver resec-
tion. Of the original TRS items, only intraoperative inferior vena
cava exposure and associated surgical procedure were significantly
associated with perioperative RBC transfusion in the present
study population. The discriminating power of the TRS in this
population was moderate and does not allow for the reliable pre-
diction of RBC transfusion.
Preoperative haemoglobin level is a consistent predictor of
transfusion, regardless of the type of surgery, but the thresholds
cited vary among studies.8,10,11,19–22 For example, in liver surgery,
Itamoto et al. found preoperative haemoglobin level at a threshold
value of 11 g/dl to be the only predictor of intraoperative
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transfusion,20 whereas Cockbain et al. identified a threshold value
of 12.5 g/dl.10 In the present population, risk for transfusion was
not significantly associated with a preoperative haemoglobin level
of <12.5 g/dl, but was significantly associated with a preoperative
haemoglobin level of <12.3 g/dl. This may reflect variability in
transfusion practices. However, even with a threshold of 12.3 g/dl,
the ROC AUC for the TRS remained moderate.
Cirrhosis is a well-known risk factor for transfusion during
liver surgery.9,23,24 However, patients with cirrhosis in the present
study displayed only a non-significant trend towards increased
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Figure 1 Frequencies of transfusion of red blood cell units in
patients undergoing liver resection (n = 205)
Table 1 Demographic and surgical data for patients undergoing liver resection
All patients Transfused patients Non-transfused patients P-value
(n = 205) (n = 48) (n = 157)
Age, years, median (IQR) 58 (17–80) 59 (23–80) 58 (17–80) 0.267
ASA class of ≥3, n (%) 13 (6.3%) 5 (10.4%) 8 (5.1%) 0.189
Aetiology, n (%)
Metastasis 92 (44.9%) 23 (47.9%) 69 (43.9%) 0.740
Hepatocellular carcinoma 42 (20.5%) 6 (12.5%) 36 (22.9%) 0.153
Cholangiocarcinoma 19 (9.3%) 5 (10.4%) 14 (8.9%) 0.778
Other reasonsa 52 (25.4%) 14 (29.2%) 38 (24.2%) 0.570
Major liver resection, n (%) 102 (49.8%) 32 (66.7%) 70 (44.6%) 0.008
Preoperative Hb <12.5 g/dl, n (%) 101 (57.4%) 30 (68.2%) 71 (53.8%) 0.114
Cirrhosis, n (%) 15 (7.4%) 5 (10.4%) 10 (6.4%) 0.354
Tumour size of >4 cm, n (%) 100 (52%) 22 (53.7%) 78 (51.7%) 0.861
IVC exposure, n (%) 83 (40.5%) 27 (56.2%) 56 (35.7%) 0.012
Associated surgical proceduresb, n (%) 113 (55.7%) 33 (70.2%) 80 (51.3%) 0.029
Death at day 30, n (%) 6 (2.9%) 6 (12.5%) 0 <0.0001
aOther reasons: adenoma, hepatic polycystosis.
bColorectal resections, bilioenteral anastomosis, pancreatic, spleen or renal resection.
ASA, American Society of Anesthesiologists; Hb, haemoglobin; IQR, interquartile range; IVC, inferior vena cava.
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Figure 2 Transfusion rates according to transfusion-related scores in
the Pulitanò et al.8 population (n = 320) and the present population
(n = 163) of patients undergoing liver resection
Table 2 Transfusion data according to the transfusion-related score
(TRS) in patients undergoing liver resection
TRS Patients,
n = 163
Patients
transfused, n = 38
RBC, units,
median (IQR)
0 15 (9.2%) 1 (6.7%) 2 (2–2)
1 35 (21.5%) 3 (8.6%) 2 (2–7)
2 44 (27.0%) 11 (25.0%) 2 (1–5)
3 47 (28.8%) 13 (27.7%) 2 (1–2)
4 21 (12.9%) 9 (42.9%) 2 (2–5)
5 1 (0.6%) 1 (100%) 1 (1–1)
IQR, interquartile range; RBC, red blood cells n (%).
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need for transfusion. This result may be related to the fact that the
number of patients with cirrhosis in the present study was rela-
tively low, which may imply insufficient power to detect this small
difference. An additional explanation may refer to the severity of
cirrhosis in resected patients. In accordance with current prac-
tices, elective liver surgery was performed in highly selected
patients with cirrhosis (i.e. those with Child–Pugh class A status
or very selected patients of Child–Pugh class B status) to limit the
risk for haemorrhage related to portal hypertension or coagula-
tion disorders.19,20
Tumour size has been proposed as an item contributing to the
TRS because of tumour rich vascularization and parenchymal
congestion.8,10 However, this item was not significantly associated
with transfusion in the present study. This discrepancy may refer
to the fact that the difficulty of the surgery seems to relate to
tumour localization more than it does to tumour size.9 Moreover,
improvements in surgical and perioperative management may
also explain this result. In the current study, among the original
TRS items, inferior vena cava exposure and concomitant extrahe-
patic procedures were the only surgical factors to be consistently
confirmed, as significantly associated with need for RBC transfu-
sion in liver surgery.
Finally, the varied case mix, different surgical techniques and
skills used and varied transfusion practices, in combination, are
likely to have impacted on the present results. All of these factors
are subject to significant variability among surgical teams and
thus it can be hypothesized that a universally reliable predictive
score is likely to be very difficult to establish.
The present study is subject to some limitations that must be
acknowledged. This was a retrospective study and lacks data jus-
tifying the delivery of transfusion for each patient (perioperative
blood loss and haemoglobin value at the time of transfusion).
Moreover, the present study population (n = 205) was smaller
than that in the study by Pulitanò et al.8 (n = 320), and the fre-
quency of cirrhosis was lower [15 patients (7.3%) versus 82
(25.6%) patients]. Nevertheless, before any prognostic model can
be extended to other populations, external validation is neces-
sary25 and should ideally be performed in a population other than
that of the initial research.
In conclusion, in the present population of patients undergoing
liver resection, the TRS appeared to be a weak predictor of
perioperative transfusion, although each of the contributing items
seemed clinically relevant. This study confirms that the external
validity of a score for predicting need for transfusion should be
subjected to further investigation before it can be implemented in
a clinical setting.
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